HERBAL DRUG TREATMENT FOR LIVER DISORDERS: THERAPEUTIC POTENTIAL OF PHYLLANTHUS AMARUS
Abstract
Liver disorders constitute a major global health challenge due to their increasing prevalence and limited therapeutic options in conventional medicine. Chronic exposure to hepatotoxins, viral infections, alcohol consumption, and metabolic imbalances often leads to progressive liver damage, including hepatitis, fatty liver disease, fibrosis, and cirrhosis. In recent years, herbal drugs have gained considerable attention as alternative or complementary therapies because of their multi-targeted actions, better safety profiles, and long history of traditional use. Medicinal plants rich in bioactive phytoconstituents such as flavonoids, lignans, tannins, and polyphenols exhibit significant hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities. Among these, Phyllanthus amarus has emerged as a well-recognized hepatoprotective herb widely used in traditional systems of medicine, particularly Ayurveda, for the treatment of jaundice and other liver disorders. The therapeutic efficacy of P. amarus is attributed to its rich phytochemical composition, especially lignans such as phyllanthin and hypophyllanthin, which play a crucial role in protecting hepatocytes from oxidative stress and toxin-induced damage. Experimental studies have demonstrated its ability to normalize liver enzymes, inhibit lipid peroxidation, and enhance endogenous antioxidant defense mechanisms. Furthermore, clinical investigations suggest its potential in managing chronic hepatitis B by suppressing viral replication and improving liver function parameters.
Downloads
References
2. Okonkwo CJ, Akah PA, Okoye TC. Enhancing the bioavailability of Phyllanthus amarus: Implications for therapeutic use in Africa. Afr J Biomed Res. 2025;28(1):12-19.
3. Tripathi S, Verma SK, Singh AK. Pharmacological activities and mechanisms of action of Phyllanthus amarus: A comprehensive review. J Herb Med. 2023;39:100652.
4. Appiah T, Mensah KB, Thomford AK. Interaction of Phyllanthus amarus extract and its lignans with cytochrome P450 enzymes and P-glycoprotein. J Ethnopharmacol. 2025;319(Pt 1):117123.
5. Gao J, Li J, Wang S. An updated review on the anti-inflammatory potential of Phyllanthus species with focus on liver-related inflammation. Chem Biodivers. 2024;21(3):e202301452.
6. Mao X, Zhang L, Wang Y, et al. A review of Phyllanthus urinaria L. in the treatment of liver diseases and its comparison with P. amarus. Front Pharmacol. 2024;15:1356782.
7. Kumar V, Sharma A, Bakshi M. Hepatoprotective activity of silymarin and Phyllanthus amarus extracts against paracetamol-induced hepatotoxicity in rats. J Exp Biol Agric Sci. 2024;12(1):45-53.
8. Yadav R, Singh N, Patel S. An updated review on hepatoprotective activity of Phyllanthus amarus. J Pharmacogn Phytochem. 2025;14(1):210-218.
9. Abubakar L, Hassan SW, Yerima M. Effect of Phyllanthus amarus leaf extract on lipid profile and liver enzymes in gentamicin-treated rats. GSC Biol Pharm Sci. 2024;26(2):104-112.
10. Abeysinghe DT, Dharmadasa RM. Phyllanthus amarus for the protection of liver health: A randomized controlled trial of Phyllpro extract. Clinical Trial Registry Record. 2024. SLCTR-2023-042.
11. Olowo OK, Ajayi AF. Phyllanthus amarus extract restored deranged biochemical and histopathological parameters in rat liver and kidney. J Morphol Sci. 2023;40:e2023021.
12. Olatunji AE, Odetola AA. Protective role of Phyllanthus amarus on lipid profile and hepatic markers in experimental hepatotoxicity. GSC Biol Pharm Sci. 2024;27(1):088-095.
13. Balogun ME, Besong EE, Obu DC. Health benefits of Phyllanthus amarus with emphasis on hepatoprotection and oxidative stress modulation. Phytomed Plus. 2025;5(1):100582.
14. Krishnan R, Meera B, Sudhakar K. Antioxidant and hepatoprotective prospects of lignans phyllanthin and hypophyllanthin from Phyllanthus amarus. Phytochem Rev. 2024;23:1102-1115.
15. Shahid M, et al. Role of glutathione in the hepatoprotective mechanism of Phyllanthus amarus against toxic liver injury. Heliyon. 2022;8(10):e10912.
16. Chauhan S, Kumar G. Antifibrotic efficacy of phyllanthin in CCl₄-induced hepatic fibrosis models. Heliyon. 2022;8(10).
17. Lee NY, Kim YJ. Induction of apoptosis in HepG2 cells and protection against CCl₄ hepatotoxicity by Phyllanthus amarus extracts enriched in phyllanthin. Nat Prod Res. 2021;35(22):4851-4856.
18. Zhang Y, Mao X, Chen H. Multi-target hepatoprotective mechanisms of P. amarus via modulation of oxidative stress and inflammatory pathways. Front Pharmacol. 2023;14:1224501.
19. Wang X, et al. Lignan-mediated inhibition of lipid peroxidation and stabilization of hepatocyte membranes by Phyllanthus amarus. Front Pharmacol. 2023;14:1224501.
20. Tan L, et al. Antiviral and anti-HBV aspects of Phyllanthus amarus in liver disease. Front Pharmacol. 2023;14:1224501.
21. Li X, Gao J. NF-κB and MAPK pathway modulation by Phyllanthus species in inflammatory liver conditions. Chem Biodivers. 2024;21(3):e202301452.
22. Mao X, et al. Comparative hepatoprotective effects of Phyllanthus amarus and P. urinaria in experimental liver injury. Front Pharmacol. 2024;15:1356782.
23. Mao X, et al. Effects of Phyllanthus species on HBV DNA suppression and liver enzymes: summary of clinical data. Front Pharmacol. 2024;15:1356782.
24. Appiah T, et al. CYP3A4 inhibition by phyllanthin and hypophyllanthin: implications for herb–drug interactions in liver patients. J Ethnopharmacol. 2025;319:117123.
25. Appiah T, et al. P-gp modulation by Phyllanthus amarus constituents and impact on hepatic drug disposition. J Ethnopharmacol. 2025;319:117123.
26. Sarmah J, Dutta P. Total phenolic and flavonoid content of Phyllanthus amarus and correlation with hepatoprotective antioxidant activity. Int J Pharm Sci Res. 2023;14(8):4012-4020.
27. Adedapo AA, et al. Role of lignans and terpenoids of P. amarus in protection against gentamicin-induced hepatotoxicity. Pharmacogn Res. 2023;15(3):554-561.
28. Kaur M, Singh J. Hepatoprotective potentials of Phyllanthus amarus: focus on antioxidant enzymes and lipid peroxidation markers. J Adv Pharm Technol Res. 2024;15(1):12-18.
29. Sharma S, et al. Comparative hepatoprotective effect of Phyllanthus amarus and silymarin in paracetamol-intoxicated rats. Indian J Pharmacol. 2023;55(4):245-252.
30. Lucchesi S, Rossi M. Herbal products for liver diseases: A therapeutic challenge in clinical practice. World J Gastroenterol. 2025;31(2):145-158.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.

.